What they were paid
Cogent Biosciences Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $72,500 | $0 | $184,615 | $0 | $257,115 |
| FY2024 | $72,500 | — | $289,562 | — | $362,062 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Cogent Biosciences, Inc. DEF 14A filed April 23, 2026, accession 0001193125-26-173834, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Cogent Biosciences pays directors a $45,000 cash retainer and $184,615 in Options.
Committees
FY2025 · as the proxy prints themAudit (Chair) · Compensation
The rest of the Cogent Biosciences board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Andrew Robbins | Director | $0 |
| Arlene M. Morris | Independent Director | $254,615 |
| Chris Cain | Independent Director | $252,115 |
| Karen Ferrante | Independent Director | $247,115 |
| Matthew E. Ros | Independent Director | $244,615 |
| Peter Harwin | Chair of the Board | $277,115 |
The full Cogent Biosciences compensation record
free company briefThis page is one director within Cogent Biosciences's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat